German study identifies therapeutic Achilles’ heel for advanced colorectal cancer
A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute has discovered a promising new approach to
another news portal
A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute has discovered a promising new approach to
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.”
T cells are an elite fighting force of the immune system, seeking out and destroying diseased cells. But in a prolonged campaign against a chronic
Tiny particles released by most human cells may be promising targets for diagnosis and treatment of an array of diseases from cancer to Alzheimer’s, but
Dentin hypersensitivity affects millions of people worldwide, yet existing treatments often provide only temporary relief.
Consider the brake. Not the engine, which gets all the attention, but the brake, the quiet thing that decides how fast a system is allowed
A team of researchers at the University of Warwick and Monash University has solved a puzzle that’s stumped drug developers for decades: how bacteria naturally
West Nile virus season is off to its earliest and worst start since 2004
A new report highlights growing demand and long waits in child mental health services.
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans
Dr Oscar is back with the latest health headlines.
Researchers at UNSW Sydney have developed a fully synthetic soft robotic heart that reproduces the complex movements and internal structures of the human heart, opening
Digestive system cancers, including hepatobiliary and gastrointestinal malignancies, remain a major global oncological burden. Although immune checkpoint inhibitors have changed the treatment landscape for some